Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
p38α Dephosphorylation by Dual-Action Inhibitors
2026-08-14
The reference study shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can reshape its activation loop to accelerate dephosphorylation by WIP1. Structural and biochemical results establish a conformational mechanism that may guide more durable and selective kinase-inhibition strategies, while also defining important limits for translating the findings into cellular inflammation or apoptosis models.
-
Mianserin HCl: Evidence From a Controlled Trial
2026-08-14
The reference study evaluated mianserin hydrochloride against amitriptyline in 39 inpatients with primary depressive illness, combining blinded clinical ratings, adverse-effect inventories, and serial plasma measurements. Therapeutic efficacy appeared similar, whereas side-effects were significantly more frequent with amitriptyline; mianserin plasma concentrations were not clearly related to clinical improvement.
-
2X Taq PCR Master Mix for Cassava Stress Genetics
2026-08-13
Learn how 2X Taq PCR Master Mix supports decision-ready cassava genotyping, cloning, and stress-gene validation. This article connects Taq enzyme chemistry with the multi-method strategy used to study cassava A20/AN1 genes.
-
NF-κB–YAP–NLRP3 Signaling in Ulcerative Colitis
2026-08-13
A 2026 study links NF-κB p65 activation to YAP inactivation, loss of NLRP3 repression, and GSDMD-dependent pyroptosis in ulcerative colitis models. Its combination of epithelial cell assays, DSS colitis, GSDMD genetic ablation, nucleoplasmic separation, and chromatin immunoprecipitation provides a mechanistic framework for studying inflammation and epithelial injury.
-
Genotyping Kit for Target Alleles: Assay Logic
2026-08-12
The Genotyping Kit for target alleles enables rapid PCR-ready DNA preparation while preserving a clear boundary between genotype and biological mechanism. This article explains how K1026 can support barrier-function studies, colony screening, and cross-species assay design without confusing allele calls with expression or phenotype data.
-
Sumatriptan Succinate: Translational Research Workflow
2026-08-12
Build receptor, inflammation, metabolism, and migraine-pathway assays around Sumatriptan Succinate rather than treating it as a single-endpoint compound. A pediatric emergency-department study provides a practical translational model for comparing route, pain-response endpoints, IV avoidance, and downstream research priorities.
-
Deep Learning of Urine Stem-Cell Mitochondria in AD
2026-08-11
This study developed a ResNet-18 deep-learning framework that classifies mitochondrial hyperfission and hyperfusion from live-cell fluorescence images, then applied it to urine-derived stem cells from cognitively normal and impaired individuals. The work suggests that non-invasive, patient-derived mitochondrial morphology could complement existing Alzheimer’s disease biomarker strategies, although larger independent cohorts and functional validation remain necessary.
-
Tolazoline: Reading Antagonist Data Correctly
2026-08-11
Tolazoline is an α2-adrenergic receptor antagonist whose receptor, ion-channel, and tissue effects should be interpreted together. This article connects structure–activity evidence with assay design for islet function research and in vitro airway smooth muscle studies.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody
2026-08-10
A scenario-based guide to using Cy3 Goat Anti-Human IgG (H+L) Antibody, SKU K1208, for sensitive human IgG detection in immunofluorescence, immunohistochemistry, flow cytometry, and ELISA. It connects assay design, controls, storage, quantitative interpretation, and practical vendor selection without overstating viability or cytotoxicity conclusions.
-
Human SAN-Plexus Assembloids Model Pacemaker Maturation
2026-08-09
A 2026 Cell Stem Cell study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac plexus, and atrial-like organoids to model neural control of pacemaker maturation and conduction. By integrating functional assays with spatial transcriptomics of human sinoatrial node tissue, the authors identify a CGPO-derived prosaposin–GPR37 signaling program that promotes pacemaker maturation.
-
Hydroxytyrosol as a Redox Probe in CKD Research
2026-08-08
Hydroxytyrosol can help researchers separate reactive oxygen species scavenging from downstream inflammatory signaling in nicotine-associated kidney injury models. This article translates the CKD literature into practical assay logic, controls, and interpretation strategies.
-
E3 Deletion Does Not Attenuate CAdV-2 Pathogenicity
2026-08-07
The January 2026 reference study identifies GXNN01, a CAdV-2 isolate carrying a 9-nucleotide E3 deletion that truncates the predicted product by three amino acids, and compares it with wild-type isolates in experimentally infected dogs. Despite this lesion, GXNN01 produced comparable clinical, virological, and histopathological disease, refining how E3 variation should be interpreted in surveillance and vaccine research.
-
SHC-1 Inhibitors Modulate CFTR Surface Abundance in Epitheli
2026-08-07
This study dissects the impact of SHC-1 inhibition on the plasma membrane availability of CFTR channels across various epithelial cell models. The findings clarify both conserved and cell-specific mechanisms in CFTR trafficking, with implications for modeling cystic fibrosis and related secretory diseases.
-
GSH-Responsive MOF Nanoparticles for Melanoma Photothermal-I
2026-08-06
Hao et al. developed a glutathione-responsive, indocyanine green-loaded MOF nanoparticle system, further functionalized with a PD-1 inhibitory peptide, to enable synergistic photothermal therapy and immune checkpoint blockade in melanoma. This approach demonstrates enhanced tumor cell ablation and immune activation, indicating a promising direction for next-generation cancer nanomedicines.
-
Redefining In Vitro Drug Response Metrics in Cancer Research
2026-08-06
Schwartz's dissertation advances the evaluation of anti-cancer drug responses by dissecting the relationship between cell proliferation arrest and cell death in vitro. This nuanced approach challenges traditional viability assessments, informing more accurate preclinical modeling and decision-making in cancer biology research.